摘要
Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remissionrate of 54. 2%, significantly higher than that in embolization with chemotherapeutic agents alone (cis-platin, adriamycin and mitomycin, 32. 1%, P<O. 01) . Morever, the adverse reactions of hydroxycamp-tothecine and cantharidin, when applied systemically, including hematuria or urodynia were successfullyeliminated.
Transcatheter arterial embolization with hydroxycamptothecine, cantharidin and cisplatin,thoroughly mixed with large doses of interferon and interleukin-2, was performed in 48 cases with unre-sectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remissionrate of 54. 2%, significantly higher than that in embolization with chemotherapeutic agents alone (cis-platin, adriamycin and mitomycin, 32. 1%, P<O. 01) . Morever, the adverse reactions of hydroxycamp-tothecine and cantharidin, when applied systemically, including hematuria or urodynia were successfullyeliminated.
